Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.040 | 19 | 33302164 | missense variant | T/A | snv |
|
Neoplasms | 0.800 | 1.000 | 5 | 2001 | 2013 | ||||||||
|
19 | 33299650 | upstream gene variant | G/A | snv | 3.5E-02 |
|
Pathological Conditions, Signs and Symptoms | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||||
|
1.000 | 0.040 | 19 | 33302225 | frameshift variant | TGTCG/- | del |
|
Neoplasms | 0.700 | 0 | |||||||||||
|
1.000 | 0.040 | 19 | 33302267 | stop gained | C/A | snv |
|
Neoplasms | 0.700 | 0 | |||||||||||
|
1.000 | 0.040 | 19 | 33302347 | frameshift variant | G/-;GG | delins |
|
Neoplasms | 0.700 | 0 | |||||||||||
|
1.000 | 0.040 | 19 | 33302274 | frameshift variant | G/- | delins |
|
Neoplasms | 0.700 | 0 | |||||||||||
|
1.000 | 0.040 | 19 | 33302213 | frameshift variant | -/TAGG | delins |
|
Neoplasms | 0.700 | 0 | |||||||||||
|
1.000 | 0.040 | 19 | 33302095 | frameshift variant | -/CA | delins |
|
Neoplasms | 0.700 | 0 | |||||||||||
|
1.000 | 0.040 | 19 | 33302197 | frameshift variant | -/G | ins |
|
Neoplasms | 0.700 | 0 | |||||||||||
|
1.000 | 0.040 | 19 | 33301423 | inframe insertion | -/TTCCACCCGCTTGCGCAGGCGGTCATTGTCACTGGTCAGCTCCAGCACCTTCTGCTG | delins |
|
Neoplasms | 0.700 | 0 | |||||||||||
|
1.000 | 0.040 | 19 | 33301463 | inframe insertion | -/GCTCCAGCACCTTCTGCTGCGTCTCCA | delins |
|
Neoplasms | 0.700 | 0 | |||||||||||
|
1.000 | 0.040 | 19 | 33302076 | frameshift variant | GGGCGCGC/- | delins |
|
Neoplasms | 0.700 | 0 | |||||||||||
|
1.000 | 0.040 | 19 | 33302295 | frameshift variant | -/G | delins |
|
Neoplasms | 0.700 | 0 | |||||||||||
|
1.000 | 0.040 | 19 | 33302294 | frameshift variant | GCGGGGC/- | delins |
|
Neoplasms | 0.700 | 0 | |||||||||||
|
1.000 | 0.040 | 19 | 33302200 | frameshift variant | -/CCGG | delins |
|
Neoplasms | 0.700 | 0 | |||||||||||
|
0.882 | 0.120 | 19 | 33301681 | missense variant | C/G | snv | 7.1E-06 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.882 | 0.120 | 19 | 33301681 | missense variant | C/G | snv | 7.1E-06 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.882 | 0.120 | 19 | 33301681 | missense variant | C/G | snv | 7.1E-06 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.925 | 0.080 | 19 | 33300221 | 3 prime UTR variant | G/A | snv | 0.16 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||||
|
0.925 | 0.080 | 19 | 33300221 | 3 prime UTR variant | G/A | snv | 0.16 |
|
Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
1.000 | 0.040 | 19 | 33302132 | missense variant | C/T | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
1.000 | 0.040 | 19 | 33302476 | 5 prime UTR variant | C/T | snv |
|
Nervous System Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
0.882 | 0.120 | 19 | 33301725 | synonymous variant | C/A | snv | 0.19 | 0.16 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
|
0.882 | 0.120 | 19 | 33301725 | synonymous variant | C/A | snv | 0.19 | 0.16 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
|
0.882 | 0.120 | 19 | 33301725 | synonymous variant | C/A | snv | 0.19 | 0.16 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 |